Abstract
Purpose: The purpose of this quality improvement project was to evaluate the use of a posttransplant screening care guidelines template performed by advanced practice providers (APPs) that included standards of care and published recommendations from the American Society for Transplantation and Cellular Therapy (ASTCT) for adult allogeneic transplant patient survivors. Methods: The theoretical framework used for this project was the Model for Improvement with the Plan-Do-Study-Act (PDSA) cycle process. A screening template was built to include institutional standards of care and recommendations from the ASTCT’s guidelines within the electronic medical record system for APP use. Weekly chart reviews were performed for data extraction and assessment for APP documentation and completion of day +30 and day +100 posttransplant recommended screenings/testing. Data were documented and tracked utilizing Excel securely over a 3-month period. Results: The APPs performed and documented the recommended screenings for 64% of patients at day +30 and for 80% of patients at day +100. Opportunities for unit and system improvements were identified to increase performance, expand utilization, allow clinicians to recognize complications earlier, and potentially improve patient outcomes. Conclusion: This project addresses implications for APP care delivery and patient outcomes. Future project cycles’ success will be ensured by utilizing the APP role at the maximum scope of practice.
References
Deming, W. E. (1986). Out of the crisis. Cambridge, MA: Center for Advanced Engineering Study.
Giaccone, D., Felicetti, F., Butera, S., Faraci, D., Cerrano, M., Vici, M. D.,…Bruno, B. (2020). Optimal delivery of follow-up care after allogeneic hematopoietic stem-cell transplant: Improving patient outcomes with a multidisciplinary approach. Journal of Blood Medicine, 11, 141–162. https://doi.org/10.2147/JBM.S206027
Hashmi, S., Lee, S., Savani, B., Burns, L., Wingard, J., Perales, M. A.,…Carpenter, P. (2018). ASBMT Practice Guidelines Committee survey on long-term follow-up clinics for hematopoietic cell transplant survivors. Biology of Blood and Marrow Transplantation, 24(6), 1107–1308. https://doi.org/10.1016/j.bbmt.2018.03.023
Institute for Healthcare Improvement. (2023). How to improve. https://www.ihi.org/resources/Pages/HowtoImprove/default.aspx
Liso, A., Neri, M., Maglietta, F., La Russa, R., & Turillazzi, E. (2017). Hematopoietic stem cell transplantation: A bioethical lens. Stem Cell International, 2017, 1–11. https://doi.org/10.1155/2017/1286246
Majhail, N., Murphy, E., Laud, P., Preussler, J., Denzen, E., Abetti, B.,...Baker, K. S. (2019). Randomized controlled trial of individualized treatment summary and survivorship care plans for hematopoietic cell transplantation survivors. Haematologica, 104(5), 1084–1092. https://doi.org/10.3324/haematol.2018.203919
Majhail, N., Rizzo, J., Lee, S., Aljurf, M., Atsuta, Y., Bonfim, C.,…Sociedade Brasileira de Transplante de Medula Óssea (SBTMO). (2012). Recommended screening and preventative practices for long-term survivors after hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation, 18, 348–371. https://doi.org/10.1016/j.bbmt.2011.12.519
McGrath, E., Schaal, A., & Pace, C. (2019). The integration of survivorship care planning at a comprehensive cancer center. Journal of the Advanced Practitioner in Oncology, 10(5), 461–468. https://doi.org/10.6004/jadpro.2019.10.5.4
National Cancer Institute. (n.d.). Allogeneic stem cell transplant. U.S. Department of Health and Human Services. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/allogeneic-stem-cell-transplant
National Cancer Institute. (n.d.). Survivorship. U.S. Department of Health and Human Services. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/survivorship
Preussler, J., Payton, T., Moore, H., Denzen, E., McCann, M., & Mau, L. W. (2021). Application and evaluation of survivorship care guides for hematopoietic cell transplantation recipients. Transplantation and Cellular Therapy Journal, 27(3), 266.e1–266.e7. https://doi.org/10.1016/j.jtct.2020.12.007
Rizzo, J. D., Wingard, J. R., Tichelli, A., Lee, S. L., Van Lint, M. T., Burns, L. J.,...Socie, G. (2006). Recommended screening and preventative practices for long-term survivors after hematopoietic cell transplantation: Joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation, 37, 249–261. https://doi.org/10.1038/sj.bmt.1705243
Spears, J. A., Craft, M., & White, S. (2017). Outcomes of cancer survivorship care provided by advanced practice RNs compared to other models of care: A systemic review. Oncology Nursing Forum, 44(1), E34–E41.
Yi, J., Sullivan, B., Leisenring, W., Majhail, N., Jim, H., Loren, A.,...Syrjala, K. (2020). Who enrolls in an online cancer survivorship program? Reach of the INSPIRE randomized controlled trial for hematopoietic cell transplantation survivors. Biology of Blood and Marrow Transplantation, 26(10), 1948–1954. https://doi.org/10.1016/j.bbmt.2020.06.017
